Vericel (VCEL) Payables (2010 - 2026)
Vericel's (VCEL) quarterly Payables came in at $19.0 million in Q1 2026, up 13.48% year-on-year from $16.8 million in Q1 2025, and up 20.1% quarter-over-quarter from $15.8 million in Q4 2025.
Vericel (VCEL) Payables (2010 - 2026) Analysis & Trends
Vericel has disclosed Payables across 17 years of filings, most recently posting $19.0 million for Q1 2026.
- Payables for Q1 2026 came in at $19.0 million, up 13.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 million (up 13.48% YoY), and the FY2025 annual result was $15.8 million, down 33.63% from the prior year.
- Payables came in at $19.0 million for Q1 2026 at Vericel, up from $15.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $25.2 million in Q2 2024 to a low of $7.8 million in Q1 2022.
- The 5-year median for Payables is $15.8 million (2025), against an average of $16.2 million.
- Across the five-year window, Payables surged 87.78% in 2022 and tumbled 49.01% in 2025, its largest moves.
- Vericel's Payables stood at $16.9 million in 2022, then soared by 32.0% to $22.3 million in 2023, then gained by 6.72% to $23.8 million in 2024, then tumbled by 33.63% to $15.8 million in 2025, then rose by 20.1% to $19.0 million in 2026.
- The last three Payables figures came in at $19.0 million (Q1 2026), $15.8 million (Q4 2025), and $15.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 19.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.01 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | 15.34 Mn |
| Jun 30, 2025 | 12.86 Mn |
| Mar 31, 2025 | 16.75 Mn |
| Dec 31, 2024 | 23.85 Mn |
| Sep 30, 2024 | 20.88 Mn |
| Jun 30, 2024 | 25.22 Mn |
| Mar 31, 2024 | 19.43 Mn |
| Dec 31, 2023 | 22.35 Mn |
| Sep 30, 2023 | 15.05 Mn |
| Jun 30, 2023 | 14.40 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | 16.93 Mn |
| Sep 30, 2022 | 8.11 Mn |
| Jun 30, 2022 | 9.68 Mn |
| Mar 31, 2022 | 7.75 Mn |
| Dec 31, 2021 | 9.02 Mn |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 8.13 Mn |